| CYSB2101216 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2400136 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-05-25 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CXSS2500007 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2025-01-22 | | Shanghai Institute of Biological Products Co Ltd | | | view |
| JYSZ2200056 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | License Renew | 2022-11-01 | | Shanghai Roche Pharmaceutical Co Ltd;Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| CYSB2101225 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | Shanghai Henlius Biologics Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CXSS2200005 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2022-01-14 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CYSB2400292 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-11-09 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| JYSZ2200058 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | License Renew | 2022-11-01 | | Shanghai Roche Pharmaceutical Co Ltd;Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| JYSB2300119 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| CYSB2500108 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2025-05-17 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSZ2200057 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | License Renew | 2022-11-01 | | Shanghai Roche Pharmaceutical Co Ltd;Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| CYSB2101224 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | Shanghai Henlius Biologics Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2400281 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-10-25 | | QILU Pharmaceutical Co Ltd | | | view |
| JYSB2300117 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| CYSB2500082 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2025-04-16 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biologics Co Ltd | | | view |
| CXSS2200015 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2022-02-17 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CYSB2101215 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2400265 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-10-09 | | QILU Pharmaceutical Co Ltd | | | view |
| JYSB2300118 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| CYSB2500083 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2025-04-16 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biologics Co Ltd | | | view |
